Susquehanna International Group’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $333K | Buy |
264,635
+62,386
| +31% | +$78.6K | ﹤0.01% | 4893 |
|
|
2025
Q1 | $185K | Buy |
202,249
+83,984
| +71% | +$76.7K | ﹤0.01% | 5562 |
|
|
2024
Q4 | $188K | Buy |
+118,265
| New | +$188K | ﹤0.01% | 5346 |
|
|
2024
Q3 | – | Sell |
-63,550
| Closed | -$104K | – | 5781 |
|
|
2024
Q2 | $104K | Sell |
63,550
-36,404
| -36% | -$59.7K | ﹤0.01% | 5084 |
|
|
2024
Q1 | $514K | Sell |
99,954
-17,652
| -15% | -$90.7K | ﹤0.01% | 3506 |
|
|
2023
Q4 | $674K | Sell |
117,606
-42,732
| -27% | -$245K | ﹤0.01% | 3426 |
|
|
2023
Q3 | $766K | Buy |
160,338
+33,017
| +26% | +$158K | ﹤0.01% | 2882 |
|
|
2023
Q2 | $541K | Sell |
127,321
-1,610
| -1% | -$6.84K | ﹤0.01% | 3514 |
|
|
2023
Q1 | $685K | Buy |
128,931
+111,139
| +625% | +$590K | ﹤0.01% | 3408 |
|
|
2022
Q4 | $112K | Sell |
17,792
-35,802
| -67% | -$225K | ﹤0.01% | 4895 |
|
|
2022
Q3 | $565K | Buy |
53,594
+43,334
| +422% | +$457K | ﹤0.01% | 3368 |
|
|
2022
Q2 | $56K | Sell |
10,260
-14,970
| -59% | -$81.7K | ﹤0.01% | 5205 |
|
|
2022
Q1 | $232K | Buy |
25,230
+10,767
| +74% | +$99K | ﹤0.01% | 4650 |
|
|
2021
Q4 | $218K | Buy |
+14,463
| New | +$218K | ﹤0.01% | 4863 |
|